Device Trial Radar · NCT07537556
Comprehensive Prospective Comparison Of Two Robotic Platforms In Anatomical Lung Resections: Clinical Outcomes And Cost-utility Analysis
Last checked: Nov 19, 2026Latest source record: Apr 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Apr 1, 2023
Primary completion
Jul 31, 2026
Study completion Jul 31, 2026
Sponsor
- Lead sponsor
- Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y CajalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 17, 2026
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal is to compare clinical outcomes, hospital costs, and cost-utility in patients undergoing anatomical lung resections with DaVinci Xi vs Versius platforms The main questions it aims to answer are: * Do patients that undergo an anatomical lung resection with DaVinci Xi have the same clinical outcomes (complications, stay...) than those who were operated with Versius? * Are anatomical lung resections performed with DaVinci Xi more expensive than those performed with Versius? * Are anatomical lung resection performed with DaVinci Xi more cost-effective than those performed with Versius? Participants already undergoing robotic anatomical lung resection as part of their regular medical care will answer quality of life questionnaires preoperatively, at 1, 3, 6, and 12 months after surgery.
Conditions
- Pulmonary Nodule, Solitary
- Lung Cancer (NSCLC)
- Pulmonary Metastases
Interventions
da Vinci Xi Surgical SystemDevice
Robotic platform used to perform anatomical lung resection (lobectomy or segmentectomy)
Versius Surgical SystemDevice
Robotic platform used to perform anatomical lung resection (lobectomy or segmentectomy)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cost/utility ratioTime frame: Data will be collected preoperatively (baseline), at 1, 3, 6, and 12 months after surgery.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hospital Universitario Ramón y Cajal
Madrid, Madrid, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.